arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Personalis, Inc.

PSNL
$15.55 ▼ -0.26 (-1.64%) at close
Healthcare ·Services-Medical Laboratories ·USServices-Medical Laboratories
36 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
17
Health
Poor
Bearish
auto_awesome

Analytical Summary

Personalis, Inc. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $1.6B
Dividend Yield —
Revenue Growth 30.0% ↗
Op. Margin -150.2% ↗
ROIC -14.3% ↘
FCF / Share $-0.28 ↘
Trailing P/E —
Price / Book 7.0x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

36-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$22.36M
↑ +30.0% —
Net Income Profit after all expenses
$-31.68M
↓ -58.0% —
Operating Margin Operating profit as % of sales
-150.2%
↑ +27.7% 1th
FCF / Share Free cash flow per share
$-0.28
↓ -13.8% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↓
2
Returns ↓
23
Financial Health ↓
7
Cash Quality ↓
65

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 10 years · 36 quarters